In Part 4 of this Exclusive Interview, Dr. Joseph Aloi concludes his discussion with Diabetes in Control publisher Steve Freed at the AACE 2016 convention in Orlando, Florida with medical developments worth watching. Joseph Aloi, MD, is Section Chief of Endocrinology and Metabolism at Wake Forest Baptist Medical Center in …

In Part 3 of this Exclusive Interview, Diabetes in Control publisher Steve Freed talks with Dr. Joseph Aloi at the AACE 2016 convention in Orlando, Florida about the use of Glucommander to prevent insulin errors. Joseph Aloi, MD, is Section Chief of Endocrinology and Metabolism at Wake Forest Baptist Medical …

In Part 2 of this Exclusive Interview, Dr. Joseph Aloi continues his discussion with Diabetes in Control publisher Steve Freed at the AACE 2016 convention in in Orlando, Florida. Dr. Aloi responds to the concern about the complication of the dosing algorithm for patients at home. Joseph Aloi, MD, is …

In Part 1 this Exclusive Interview, Dr. Joseph Aloi joins Diabetes in Control publisher Steve Freed for a discussion at the AACE 2016 convention in in Orlando, Florida, to discuss software that can help treat diabetic ketoacidosis and reduce hypoglycemic events, and the difficulties of treating the condition. Joseph Aloi, …

Typically our diabetes patients have changes in vision and they totally ignore them. They blame it on age, environment, old glasses and any other excuse. We as medical professionals don’t stress the possible changes enough because we are more focused on things like neuropathy and kidney failure. This means that …

In part 3 of this Exclusive Interview, Dr. Chous gives a brief tour of what's on the horizon in treating diabetic eye disease.

In this week's Homerun Slides, the Canadian Diabetes Association lists insulin action and examples of insulin initiation and titration regimens in people with type 2.

Regulation of proinsulin conversion: PC2 and PC1/3 are Ca2+-dependent enzyme activities with an acidic pH 5 – 5.5 optimum. Fortunately, the beta granule contains an intraorganellar environment of 1 – 10 mM free Ca2+ and acidic pH 5.5, which ideally suits the requirements for optimal PC2, PC1/3 and CP-H activities within this organelle.

Do you look to Diabetes in Control to keep you updated with new treatments? Follow the link to share your opinion.

First a little explanation about the new unique product with its own delivery system. This is not only a medication but also a matchstick-sized osmotic mini pump that is the size of a match and is placed just beneath the skin to deliver a continuous and consistent flow of medication for a year.